Variants in AKT2 and PTEN have been associated with type 2 diabetes risk; their presence reduces activity of the insulin signalling pathway, leading to reduced glucose uptake and insulin resistance in insulin-responsive tissues. The gene discussed is INS; the disease is type 2 diabetes mellitus.